Answers are grounded in this paper and cite their sources.
Photo essay reveals rapid identification of Candida glabrata in fungal keratitis, suggesting adjusted antifungal therapy.
The aim of the study was to demonstrate how CHROMagar™ Candida enables same-day presumptive identification of Candida glabrata in corneal scrapings from fungal keratitis and to discuss species-specific therapeutic considerations. A 69-year-old female with postsurgical microbial keratitis underwent corneal scraping. The samples were inoculated on CHROMagar™ Candida . Colony color at 24 h predicted C. glabrata , later confirmed by Matrix-Assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF). Antifungal therapy was tailored accordingly. At 24 h, small pale pink colonies suggested C. glabrata . Empirical natamycin was switched to topical amphotericin B and voriconazole, leading to clinical resolution by week 5. CHROMagar™ Candida provides a rapid, low-cost presumptive ID of C. glabrata in keratitis, guiding early targeted therapy in resource-limited settings.
No takes yet. Share an insight, caveat, or question.
Sagar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: